| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |